131220 — Daihan Scientific Co Balance Sheet
0.000.00%
- KR₩32bn
- KR₩28bn
- KR₩81bn
Annual balance sheet for Daihan Scientific Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 9,340 | 10,115 | 12,811 | 13,376 | 16,121 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 6,385 | 6,247 | 6,751 | 6,907 | 9,397 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 36,289 | 38,963 | 44,424 | 46,980 | 52,792 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 17,091 | 18,980 | 18,153 | 19,620 | 18,348 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 54,920 | 59,453 | 63,996 | 67,814 | 72,225 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 13,328 | 11,922 | 14,709 | 13,698 | 14,339 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 22,295 | 23,021 | 24,799 | 25,591 | 27,251 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 32,625 | 36,432 | 39,197 | 42,223 | 44,975 |
| Total Liabilities & Shareholders' Equity | 54,920 | 59,453 | 63,996 | 67,814 | 72,225 |
| Total Common Shares Outstanding |